Business
Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom
CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company
About this update from Onconetix, Inc.
[{"type":"text","content":"CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that scientists from its research partner, The University of Oxford, will present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom on Monday, September 5th, 2022. Sunetra Gupta, Ph.D., Professor of Theoretical Epidemiology at The University of Oxford and current member of the BWV Scientific Advisory Board, will present BWV’s approach to a universal influenza vaccine, BWV-101, containing epitopes of limited variability identified for influenza H1, H3, and influenza B. The Company is also developing a standalone H1 pre-pandemic vaccine containing epitopes of limited variability, BWV-102. “We are honored for Dr. Gupta to present our technology to such an esteemed group of colleagues in Oxford, where it all began for Blue Water Vaccines in 2019,” said Joseph Hernandez, Chairman and Chief Executive Officer of Blue Water Vaccines. “There is an immense global need for a lasting, efficacious, influenza vaccine and we look forward to collaborating with all in attendance at such a dedicated event.” In July 2019, the Company entered into an exclusive, global license agreement relating to the use of epitopes of limited variability for the development and commercialization of influenza vaccine candidates. In addition, BWV and Oxford entered into a Sponsored Research Agreement in December 2019, extended in May 2022, to fund research and optimization of epitopes of limited variability for influenza vaccine candidate development. BWV’s management will be available during the conference for one-on-one meetings. Interested parties may request a one-on-one meeting at [email protected] or contact BWV at (513) 620-4101. About Blue Water Vaccines Blue Water Vaccines Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center, and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will ...